Spoken Alpha
KORU Medical Systems, Inc.
KORU Medical manufactures and commercializes the FREEDOM Infusion System, a mechanical subcutaneous drug delivery platform consisting of syringe drivers, tubing, and safety needle sets.
KORU Medical Systems, Inc is a Healthcare company operating in Medical Instruments & Supplies with a $148.4M market cap.
KRMD beat consensus EPS by 1.0% in Q2 FY2026, reported Aug 4, 2026.
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KRMD.
$ curl https://api.spokenalpha.com/v1/companies/KRMDFAQ
Spoken Alpha indexes KRMD's earnings call transcripts at https://spokenalpha.com/companies/KRMD. Each call links to attributed speakers and parsed analyst Q&A. KORU Medical Systems, Inc.'s own investor relations page is at https://investors.korumedical.com/.
KORU Medical Systems, Inc. (KRMD) held its most recent earnings call on 2026-08-05, covering fiscal Q2 2026.
KORU Medical Systems, Inc. (KRMD) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | $0.01 | $-0.02 | +100.0% | $12.0M | — | — | EODHD |
| Q1 FY2026 | 2026-05-05 | $-0.02 | $-0.01 | -100.0% | $11.8M | — | — | EODHD |
| Q4 FY2025 | 2026-03-03 | $0.01 | $-0.02 | +100.0% | $10.9M | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $-0.02 | $-0.02 | +16.0% | $10.4M | — | — | EODHD |
| Q2 FY2025 | 2025-08-05 | $0.01 | $-0.02 | +100.0% | $10.2M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $-0.03 | $-0.03 | 0.0% | $9.6M | — | — | EODHD |
| Q4 FY2024 | 2025-03-11 | $-0.03 | $-0.03 | 0.0% | $8.8M | — | — | EODHD |
| Q3 FY2024 | 2024-11-12 | $-0.01 | $-0.04 | +75.0% | $8.2M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.01 | $-0.04 | +75.0% | $8.4M | — | — | EODHD |
| Q1 FY2024 | 2024-04-30 | $-0.02 | $-0.04 | +50.0% | $8.2M | — | — | EODHD |
| Q4 FY2023 | 2024-03-12 | $-0.03 | $-0.04 | +25.0% | $7.2M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.03 | $-0.05 | +40.0% | $7.0M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-0.05 | $-0.06 | +16.7% | $6.9M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $-0.05 | $-0.05 | 0.0% | $7.4M | — | — | EODHD |
| Q4 FY2022 | 2023-03-07 | $-0.04 | $-0.06 | +33.3% | $7.3M | — | — | EODHD |
| Q3 FY2022 | 2022-11-08 | $-0.03 | $-0.05 | +40.0% | $7.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-02 | $-0.06 | $-0.06 | 0.0% | $6.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-03 | $-0.05 | $-0.06 | +16.7% | $6.2M | — | — | EODHD |
| Q4 FY2021 | 2022-03-01 | $-0.02 | $-0.03 | +33.3% | $6.5M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $-0.02 | $-0.02 | 0.0% | $6.0M | — | — | EODHD |
Source: EODHD. KRMD reported actuals as published; sparse fields render as —.